NCT01469858 Perception and Multisensory Integration in Neurological Patients Using fMRI Status UNKNOWN Phase NA
NCT01325571 A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis Status COMPLETED Phase PHASE3
NCT01268280 Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis Status TERMINATED Phase PHASE2
NCT01105923 Study of an Intervention to Improve Problem List Accuracy and Use Status UNKNOWN Phase NA
NCT00997412 Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis Status UNKNOWN Phase NA
NCT00987116 Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis Status COMPLETED Phase PHASE4
NCT00774462 Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT00727194 Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis Status TERMINATED Phase PHASE2
NCT00716066 Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00424489 Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis Status TERMINATED Phase PHASE1
NCT00309101 An Open Study for Steroid Resistant, Non-Thymectomized MG Patients Status COMPLETED Phase PHASE3
NCT00309088 FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients Status COMPLETED Phase PHASE3
NCT00306033 Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis Status COMPLETED Phase PHASE3
NCT00294658 Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Status COMPLETED Phase PHASE3
NCT00004682 Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis Status TERMINATED Phase NA